SciELO - Scientific Electronic Library Online

 
vol.83 issue4Resilience and emotional intelligence in patients diagnosed with substance use disorder.Progressive myoclonic epilepsies author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de Neuro-Psiquiatría

Print version ISSN 0034-8597

Abstract

MARINOS SANCHEZ, Evelyn; ESPINO ALVARADO, Poul; RODRIGUEZ, Liliana  and  BARRETO ACEVEDO, Elliot. Neurological manifestations associated with COVID-19 in Edgardo Rebagliati Martins Hospital, Peru. Rev Neuropsiquiatr [online]. 2020, vol.83, n.4, pp.243-256. ISSN 0034-8597.  http://dx.doi.org/10.20453/rnp.v83i4.3890.

The disease caused by coronavirus 2 associated with severe acute respiratory syndrome (SARS-CoV-2) is formally known as Coronavirus Disease 2019 (COVID-19). Its main focus is the respiratory system, but neurological manifestations have also been described.

Objective:

To describe the neurological manifestations in patients with COVID-19 at the Edgardo Rebagliati Martins hospital.

Material and Methods:

An observational, descriptive, cross-sectional study, using the electronic medical records of COVID-19 hospitalized and discharged during the April-August 2020 period. The patients were classified as carrying neurological manifestations of the central and peripheral nervous system.

Results:

Of 1122 patients, 354 (31.5%) had some neurological manifestation while 26.9% showed symptoms of the central nervous system (CNS), and 8.4% of the peripheral nervous system (PNS). Among the CNS manifestations, the most frequent symptom was headache (19.7%), and as pathologies: encephalopathy (4.7%), ischemic stroke (2.7%), acute symptomatic seizure (0.5%), cerebral hemorrhage (0,4%), encephalitis (0.2%). From the PNS manifestations, myalgia (3.4%), anosmia (3.1%) and dysgeusia (2.9%) predominated and, as pathologies, rhabdomyolysis (1.3%) and acute polyradiculoneuropathy (0.3%). The fatality rate reached 32.7% with an OR of 1.4.

Conclusions:

Patients with SARS-CoV-2 infection can present neurological symptoms as those described in the present study, manifestations that should be considered in their timely and integrated care.

Keywords : Neurological Manifestations; COVID-19; SARS-CoV-2..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )